Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
6/2003
vol. 105 abstract:
Review article
New methods of therapy for ocular inflammatory autoimmune diseases
Agnieszka Kubicka-Trząska
1
,
Anetta Undas
2
Online publish date: 2003/12/21
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The authors review the current literature, regarding the efficacy and safety of new methods of therapy for ocular inflammatory autoimmune diseases: scleritis, pemphigoid and uveitis. Immunomodulation therapy is increasingly being used in various ocular inflammatory diseases, to avoid the effects of long-term steroid and immunosuppressive therapy and to induce remission in chronic disease. This therapy seems to be effective specially in treating resistant disease with relative safety. New approaches to therapy of intraocular inflammatory diseases will emphasize less immunosuppressive drugs and modification of the immune system with anti-MHC II, anti-adhesion molecules, anticytokines monoclonal antibodies, therapy with cytokines antagonists, intravenous immunoglobulin therapy, INF alpha therapy, antigen specific tolerancing therapy and gene therapy. Advances in the understanding of pathogenesis and in diagnostic techniques in various ocular inflammatory entities, will serve as a driving force for these new methods of treatment.
keywords:
cytokines, adhesion molecules, monoclonal antibodies, scleritis, ocular pemphigoid, uveitis |
|